Abstract
The aim of the study is to screen patients for homocystinuria with and without cataract and analyse for homocystine and methionine. Fifty-eight samples from 29 patients, i.e., plasma and urine collected after overnight fasting were analysed by the screening test for homocystine, and paper chromatography for homocystine and methionine. Out of 29 homocystinuric patients, 24 had cataract. Only one had appreciable amounts of methionine in his serum. He also had mental retardation as expected and belongs to Type I. The other types did not have methionine but had only homocystine. There was no mental retardation or ectopia lentis. So they belonged to Types II, III or IV. As there is excess methionine in Type I, with low cystine, cataract may be due to deficiency of cysteine and reduced glutathione and might be averted by suitable therapy, i.e., high cystine-low methionine diet with B6. In other types with low methionine, cataract may be due to decreased availability of amino acids for the synthesis of lens proteins; the treatment of choice should be B12, and folate with methionine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ueland PM, Refsum H. Plasma Homocysteine in cardiovascular disease.Fundam & Clin Cardiol 1992; 8: 183–236.
Murray RK, Granner DK, Mayes PA and Rodevell VW. Catabolism of the carbon skeletons of amino acids. InHarper’s Biochemistry, 23rd edn. 1993; 310.
Mudd SH, Skovby F, Levy HL. The natural history of homocystinuria due to cystathione β-synthetase deficiency.Am J Hum Genet 1985; 37: 1–31.
Mudd SH, Levy HL. Disorders of transulfuration. In: Standbury JB, ed.Metabolic Basis of Inherited Diseases, New York; McGraw-Hill, 1983; 522–529.
Boers GHJ, Smals AGH, Drayer JIM. Pyridoxine treatment does not prevent homocystenemia after methionine loading in adult homocystinuria patients.Metab Cli Exp 1983; 32: 392–397.
Perry TL, Hansen S, Love DL. Treatment of homocystinuria with a low methionine diet supplemental cystine and methyl donor.Lancet 1968; 2: 427.
Presley G, Stinson IN. Homocystinuria and ocular defects.Am J Ophthalmol 1968; 66: 884.
Spaeth GL, Barber. Homocystinuria — its ocular manifestations.J Pediatr Opthalmol 1966; 3: 42.
Heaver WH. In: Vester B, Rasmussen K eds.Ocular Pharmacogenetics, 2nd edn. HPLC method for rapid and accurate determination of homocysteine in plasma, serum.Eur J Clin Biochem 1975; 29 : 549–554.
Varley H, Gowenlock AH, Bell M. Screening procedures for inherited disorders. In:Practical Clinical Biochemistry, Vol. I, London, William Heinemann 1990; pp. 523–524.
Ramakrishan S, Prassanan KG, Rajan R. Text Book of Medical Biochemistry, 2nd edn. 1990; 54 pp.
Rathbun WB, Bovis MG. Activity of glutathione peroxidase and glutathione reductase in the human lens.Curr Eye Res 1986; 5: 381–385.
Spector A, Huwang RRC. Wang GN, Schmidt. Does elevated glutathione protect the cell from H2O2 insult.Exp Eye Res 1987; 45: 453–465.
Winkler BS. In vitro oxidation of ascorbic acid and its prevention by GSH.Biochem Biophys Acta 1987; 925: 258–264.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sulochana, K.N., Amirthalakshmi, S., Vasanthi, S.B. et al. Homocystinuria with congenital/developmental cataract. Indian J Pediatr 67, 725–728 (2000). https://doi.org/10.1007/BF02723928
Issue Date:
DOI: https://doi.org/10.1007/BF02723928